ReferenceFeaturedGHK-Cu
Copper tripeptide complex — HPLC-verified, COA per lot.
Heads up·Online ordering is currently unavailable while we finish setting up the store. Questions? Email support@elev8labsrx.com.
Reference standard
GLOW70 research peptide blend.
Reference standardSize
Price
$90.00
SKU GLOW70-70MG
Complimentary shipping over $200
For research use only. Not for human consumption.
Every lot is third-party assayed by HPLC. A lot-specific COA ships with the product and is mirrored to the buyer account.
Real COAs are published per lot when shipments begin. Sample COA available on request.
Scientific Details
GLOW70 is a research peptide reference standard supplied for laboratory characterization and in-vitro experimental work. The molecule is not currently indexed in the PubChem compound database; structural details and analytical specifications are established through the supplier's Certificate of Analysis and lot-release documentation rather than through a public chemical-registry citation. The peer-reviewed literature on this specific designation is comparatively limited; researchers using the material are advised to consult the supplier's COA for sequence, molecular-weight, and purity values, and to corroborate any literature claims against primary sources. The reference material supplied here is intended for laboratory characterization, in-vitro signaling assays, and analytical-method development only. For research use only; not for human consumption, medical use, cosmetic application, or veterinary application. Researchers should consult the supplier-supplied COA and primary literature for context-specific experimental conditions and validated assay controls.
Detailed molecular-profile information for GLOW70 is established through the supplier's Certificate of Analysis rather than through a public chemical-registry citation. Researchers using the reference standard should refer to the COA distributed with each lot for sequence, molecular weight, and any reported pharmacokinetic descriptors. Where peptide reference standards are concerned, lyophilized formulations are typically characterized by mass-spectrometry molecular-ion confirmation, reverse-phase HPLC purity, and amino-acid analysis as standard release-specification parameters. The molecule's interaction profile in laboratory research should be framed by the experimental investigator according to the published or supplier-provided context for the specific lot in hand, rather than as established receptor-pharmacology characteristics. All activity descriptors should be sourced from the COA and primary literature available to the research group. Structural confirmation of supplied lots is established by the lot-specific COA reported on each Certificate of Analysis.
Experimental contexts for which laboratory researchers have requested this reference standard include analytical-method development, in-vitro characterization assays, and investigator-defined research paradigms in cosmetic-chemistry research, peptide-formulation studies, and skin-cell-research model systems. Because the molecule's published-literature footprint is comparatively limited, researchers should design experimental protocols based on the COA-specified molecular profile and on first-principles peptide-research best practice, rather than on established receptor-pharmacology assumptions. Use in laboratory research extends to whatever experimental contexts the investigator's institutional review process has approved for novel or proprietary research peptides. The reference material is supplied for in-vitro and analytical experimental contexts only, with no associated guidance for human, clinical, cosmetic-product, or veterinary application. Researchers should consult primary literature (where available) and the supplier-supplied COA when designing context-specific protocols.
Each lot is characterized by reverse-phase HPLC for chromatographic purity and by mass spectrometry for molecular-ion confirmation. Purity is reported as an HPLC-area percentage on the Certificate of Analysis distributed with every lot, alongside the molecular-weight match within instrument tolerance. Peptide content where applicable is determined by amino-acid analysis or nitrogen-content assay following the analytical method specified on the COA. Residual solvent and water content are reported categorically when these parameters are part of the lot's release specification. The COA is the primary citation chain for this reference standard and records the lot identifier, manufacturing date, and analytical method versions used — providing a traceable provenance chain from synthesis through release. Researchers requiring batch-level analytical detail should reference the COA distributed with the supplied material.
For laboratory storage, the lyophilized reference standard should be held at −20°C in its sealed, light-protected container until ready for analytical use. Allow vials to equilibrate to ambient temperature before opening to avoid moisture condensation on the lyophile. Reconstitution for in-vitro experimental use is typically performed in bacteriostatic water or a researcher-selected buffer compatible with the downstream assay; once reconstituted, store the working solution at 2–8°C and characterize stability in the relevant buffer prior to extended storage. Avoid repeated freeze-thaw cycles of reconstituted material — single-use aliquots are preferred for experiments where peptide integrity is assay-critical. These handling parameters reflect general best-practice for lyophilized peptide reference standards and do not constitute preparation guidance for human, cosmetic, or veterinary application.
A selection of reference standards from the catalog.
ReferenceFeaturedCopper tripeptide complex — HPLC-verified, COA per lot.
ReferenceFeaturedTriple-agonist research standard — four size variants.
ReferenceFeaturedPentapeptide GH secretagogue — research standard.
ReferenceFeaturedThymosin-beta-4 fragment — research standard.